Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-26T20:46:11.015Z Has data issue: false hasContentIssue false
  • English
  • Français

Dietary fatty acids and cardiovascular disease

Published online by Cambridge University Press:  11 November 2011

A. M. Salter
A. M. Salter*
Affiliation:
Division of Nutritional Sciences, School of Biosciences, University of Nottingham, Sutton Bonington Campus, Leicestershire, Loughborough LE12 5RD, UK
*
†E-mail: andrew.salter@nottingham.ac.uk
Get access

Abstract

In 1991, the Committee on Medical Aspects of Food Policy produced a report on the dietary reference values for food energy and nutrients for groups of people in the United Kingdom. The resulting recommendations, which included specific limits for intakes of total, saturated, trans- and cis-polyunsaturated fatty acids (PUFA) have remained a cornerstone of public health policy ever since, and similar recommendations have been adopted by the World Health Organization. These recommendations were made largely on the basis of specific effects of these fatty acids on the risk of developing atherosclerotic cardiovascular disease (CVD). The intervening years have seen a plethora of human epidemiological and intervention trials to further elucidate the specific relationship between dietary fatty acid intake, plasma lipids and lipoproteins and cardiovascular morbidity and mortality. A number of recent meta-analyses and systematic reviews have revisited the role of specific dietary fatty acid classes and CVD risk. In general, these continue to support a link between saturated fatty acids (SFA) and CVD morbidity/mortality. They also highlight the potent adverse effects of trans fatty acids derived from partially hydrogenated vegetable oil. The most recent data suggest that replacing SFA with cis-PUFA (primarily linoleic acid) has the greatest impact on reducing CVD risk. Evidence of specific beneficial effects of n-3 PUFA is generally stronger for secondary, rather than primary, CVD risk, and it is restricted to very long chain fatty acids of marine origin as opposed to alpha-linolenic acid. Taken together, these data suggest that recent focus on dietary n-6-to-n-3 PUFA ratios may have been misguided, and that future strategies should focus on replacing dietary SFA with total PUFA, rather than concentrating on n-6 : n-3 PUFA ratio.

Keywords

cardiovascular diseasecoronary heart diseasedietfatty acids
Type
Full Paper
Information
animal , Volume 7 , Issue s1: The 8th International Symposium on the Nutrition of Herbivores (ISNH8) 6 – 9th September 2011, Aberystwyth (UK) , March 2013 , pp. 163 - 171
Copyright
Copyright © The Animal Consortium 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bang, HO, Dyerberg, J 1972. Plasma lipids and lipoproteins in Greenlandic west coast Eskimos. Acta Medica Scandinavica 192, 85–94.Google Scholar
Bang, HO, Dyerberg, J 1980. Lipid metabolism and ischemic heart disease in Greenland Eskimos. In Advances in nutrition research (ed. H Draper), pp. 1–22. Plenum Press, New York, USA.Google Scholar
Bauman, DE, Lock, AL, Corl, BA, Ip, C, Salter, AM, Parodi, PW 2006. Milk fatty acids and human health: potential role of conjugated linoleic acid and trans fatty acids. In Ruminant physiology: digestion, metabolism and impact of nutrition on gene expression, immunology and stress (ed. K Sejrsen, T Hvelplund and MO Nielsen), pp. 529–561. Wageningen Academic Publishers, Wageningen, the Netherlands.Google Scholar
Bendsen, NT, Christensen, R, Bartels, EM, Astrup, A 2011. Consumption of industrial and ruminant trans fatty acid and risk of coronary heart disease: a systematic review and meta-analysis of cohort studies. European Journal of Clinical Nutrition 65, 773–783.CrossRefGoogle ScholarPubMed
Breslow, JL 2006. N-3 fatty acids and cardiovascular disease. American Journal of Clinical Nutrition 83 (suppl.), 1477S–1482S.CrossRefGoogle ScholarPubMed
Brouwer, IA, Wanders, AJ, Katan, MB 2010. Effect of animal and industrial trans fatty acids on HDL and LDL cholesterol levels in humans – a quantitative review. PLoS One 5, e9434.CrossRefGoogle ScholarPubMed
Burr, ML, Ashfield-Watt, PAI, Dunstan, FDJ, Fehily, AM, Breay, P, Ashton, T, Zotos, PC, Haboubi, NA, Elwood, PC 2003. Lack of benefit of dietary advice to men with angina: results of a controlled trial. European Journal of Clinical Nutrition 57, 193–200.CrossRefGoogle ScholarPubMed
Burdge, GC, Calder, PC 2005. Conversion of α-linolenic acid to longer chain polyunsaturated fatty acids in human adults. Reproduction, Nutrition and Development 45, 581–597.CrossRefGoogle ScholarPubMed
Chardigny, J-M, Destaillats, F, Malpuech-Brugère, C, Moulin, J, Bauman, DE, Lock, AL, Barbano, DM, Mensink, RP, Bezelgues, J-P, Chaumont, P, Combe, N, Cristiani, I, Joffre, F, German, JB, Dionisi, F, Boirie, Y, Sébédio, J-L 2008. Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans Fatty Acids Collaboration (TRANSFACT) study. American Journal of Clinical Nutrition 87, 558–566.CrossRefGoogle ScholarPubMed
De Goede, J, Verschuren, WMM, Boer, JMA, Kromhout, D, Geleijnse, JM 2011. Alpha-linolenic acid intake and 10-year incidence of coronary heart disease and stroke in 20 000 middle-age men and women in the Netherlands. PLoS One 6, e17967.CrossRefGoogle Scholar
Department of Health 1991. Report on health and social subjects 41. Dietary reference values for food nutrients for the United Kingdom. Report of the Panel on Dietary Reference Values of the Committee on Medical Aspects of Food Policy. HMSO, London.Google Scholar
Department of Health 1994. Report on health and social subjects 46. Nutritional aspects of cardiovascular disease. Report of the Cardiovascular Review Group Committee on Medical Aspects of Food Policy. HMSO, London.Google Scholar
Elwood, PC, Pickering, JE, Givens, DI, Gallacher, JE 2010. The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: an overview of the evidence. Lipids 45, 925–939.CrossRefGoogle ScholarPubMed
Food and Agriculture Organization (FAO) of the United Nations 2010. Fats and fatty acids in human nutrition. Report of an Expert Consultation. FAO Food and Nutrition Paper 91, FAO, Rome (Final report).Google Scholar
Givens, DI, Gibbs, RA 2008. Current intakes of EPA and DHA in European populations and the potential of animal-derived foods to increase them. Proceedings of the Nutrition Society 67, 273–280.CrossRefGoogle Scholar
Harris, WS 2006. The omega-6/omega-3 ratio and cardiovascular disease risk: uses and abuses. Current Atherosclerosis Reports 8, 453–459.Google Scholar
Harris, WS 2010. The omega-3 index: clinical utility for therapeutic intervention. Current Cardiology Reports 12, 503–508.CrossRefGoogle ScholarPubMed
Hegsted, DM, McGandy, RB, Myers, ML, Stare, FJ 1965. Quantitative effects of dietary fat on serum cholesterol in man. American Journal of Clinical Nutrition 17, 281–295.Google Scholar
Hegsted, DM, Ausman, LM, Johnson, JA, Dallal, GE 1993. Dietary fat and serum lipids: an evaluation of experimental data. American Journal of Clinical Nutrition 57, 875–883.Google Scholar
Hooper, L, Summerbell, CD, Thompson, R, Sills, D, Roberts, FG, Moore, H, Davey Smith, G 2011. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database of Systematic Reviews 7, CD002137.Google Scholar
Hooper, L, Harrison, RA, Summerbell, CD, Moore, H, Worthington, HV, Ness, A, Capps, N, Davey Smith, G, Riemersma, R, Ebrahim, S 2004. Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database of Systematic Reviews 4, CD003177.Google Scholar
Hooper, L, Thompson, RL, Harrison, RA, Summerbell, CD, Ness, AR, Moore, HJ, Worthington, HV, Durrington, PN, Higgins, JPT, Capps, NE, Riemersma, RA, Ebrahim, SBJ, Davey Smith, G 2006. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. British Medical Journal 332, 752–760.Google Scholar
Jakobsen, MU, O'Reilly, EJ, Heitmann, BL, Pereira, MA, Bälter, K, Fraser, GE, Goldbourt, U, Hallmans, G, Knekt, P, Liu, S, Speigelman, D, Stevens, J, Virtamo, J, Willett, WC, Ascherio, A 2009. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. American Journal of Clinical Nutrition 89, 1425–1432.CrossRefGoogle ScholarPubMed
Katan, MB, Brouwer, IA, Clarke, R, Geleijnse, JM, Mensink, RP 2010. Saturated fat and heart disease. American Journal of Clinical Nutrition 92, 459–460.Google Scholar
Keys, A, Andrerson, JT, Grande, F 1965. Serum cholesterol response to changes in diet. IV. Particular saturated fatty acids in the diet. Metabolism 14, 776–787.CrossRefGoogle ScholarPubMed
Keys, A, Aravanis, C, Blackburn, HW, Van Buchem, FS, Buzina, R, Djordjević, BD, Dontas, AS, Fidanza, F, Karvonen, MJ, Kimura, N, Lekos, D, Monti, M, Puddu, V, Taylor, HL 1966. Epidemiological studies related to coronary heart disease: characteristics of men aged 40–59 in seven countries. Acta Medica Scandinavica Supplement 460, 1–392.Google ScholarPubMed
Mangiapane, EH, Salter, AM 1999. Diet, lipoproteins and coronary heart disease: a biochemical perspective. Nottingham University Press, UK.Google Scholar
Marik, PE, Varon, J 2009. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clinical Cardiology 32, 365–372.CrossRefGoogle ScholarPubMed
Mensink, RP, Katan, MB 1992. Effects of dietary fatty acids on serum lipids and lipoproteins: a meta-analysis of 27 trials. Arteriosclerosis and Thrombosis 12, 911–919.CrossRefGoogle ScholarPubMed
Mensink, RP, Zock, PL, Kester, ADM, Katan, MB 2003. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. American Journal of Clinical Nutrition 77, 1146–1155.CrossRefGoogle ScholarPubMed
Mente, A, de Koning, L, Sannon, HS, Anand, SS 2009. A systematic review of evidence supporting a causal link between dietary factors and coronary heart disease. Archives of Internal Medicine 169, 659–669.CrossRefGoogle ScholarPubMed
Micha, R, Wallace, SK, Mozaffarian, D 2010. Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus. Circulation 121, 2271–2283.CrossRefGoogle ScholarPubMed
Mozaffarian, D, Rimm, EB 2006. Fish intake, contaminants and human health. Journal of the American Medical Association 296, 1885–1899.CrossRefGoogle ScholarPubMed
Mozaffarian, D, Clarke, R 2009. Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. European Journal of Clinical Nutrition 63, S22–S33.CrossRefGoogle ScholarPubMed
Mozaffarian, D, Micha, R, Wallace, S 2010. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Medicine 7, e1000252.CrossRefGoogle ScholarPubMed
Mozaffarian, D, Ascherio, A, Hu, FB, Stampfer, MJ, Willett, WC, Siscovck, DS, Rimm, EB 2005. Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation 111, 157–164.CrossRefGoogle ScholarPubMed
Salter, AM, White, DA 1996. Effects of dietary fat on cholesterol metabolism: regulation of plasma LDL concentration. Nutrition Research Reviews 9, 241–257.CrossRefGoogle Scholar
Scarborough, P, Bhatnagar, P, Wickramasinghe, K, Smolina, K, Mitchell, C, Rayner, M 2010a. Coronary heart disease statistics 2010a edition. British Heart Foundation.Google Scholar
Scarborough, P, Rayner, M, van Dis, I, Norum, K 2010b. Meta-analysis of the effect of saturated fat intake on cardiovascular disease: overadjustment obscures true associations. American Journal of Clinical Nutrition 92, 458.CrossRefGoogle ScholarPubMed
Simopoulos, AP 2008. The importance of the omega-6/omega-3 fatty acid ration in cardiovascular disease and other chronic diseases. Experimental Biology and Medicine 233, 674–688.CrossRefGoogle Scholar
Siri-Tarino, PW, Sun, Q, Hu, FB, Krauss, RM 2010a. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. American Journal of Clinical Nutrition 91, 535–546.CrossRefGoogle ScholarPubMed
Siri-Tarino, PW, Sun, Q, Hu, FB 2010b. Reply to P Scarborough et al. American Journal of Clinical Nutrition 92, 459.CrossRefGoogle Scholar
Siri-Tarino, PW, Sun, Q, Hi, FB, Krauss, RM 2010c. Response to MB Katan et al. American Journal of Clinical Nutrition 92, 460–461.CrossRefGoogle Scholar
Skeaff, CM, Miller, J 2009. Dietary fat and coronary heart disease: summary of evidence from prospective cohort and randomised controlled trials. Annals of Nutrition and Metabolism 55, 173–201.CrossRefGoogle ScholarPubMed
Soedamah-Muthu, SS, Ding, EL, Al-Delaimy, WK, Hu, FB, Engberink, MF, Willett, WC, Geleijnse, JM 2011. Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: dose–response meta-analysis of prospective cohort studies. American Journal of Clinical Nutrition 93, 158–171.CrossRefGoogle ScholarPubMed
Standing Advisory Committee on Nutrition ( SACN ) 2004. Advice on fish consumption: benefits and risks. TSO, London, UK.Google Scholar
Standing Advisory Committee on Nutrition ( SACN ) 2007. Position statement by the Standing Advisory Committee on Nutrition: update on trans fatty acids and health. TSO, London, UK.Google Scholar
Stanley, JC, Elsom, RL, Calder, PC, Griffin, BA, Harris, WS, Jebb, SA, Lovegrove, JA, Moore, CS, Riemersma, RA, Sander, TAB 2007. UK Food Standards Agency Workshop Report: the effects of the dietary b-6 : n-3 fatty acid ratio on cardiovascular health. British Journal of Nutrition 98, 1305–1310.CrossRefGoogle Scholar
Tanaka, T, Shen, J, Abecasis, GR, Kisialiou, A, Ordovas, JM, Guralnik, JM, Singleton, A, Bandinelli, S, Cherubini, A, Arnett, D, Tsai, MY, Ferrucci, L 2009. Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI study. PLoS Genetics 5, e1000338.CrossRefGoogle ScholarPubMed
Unal, B, Critchley, JA, Capewell, S 2004. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 109, 1101–1107.CrossRefGoogle ScholarPubMed
Wang, C, Harris, WS, Chung, M, Lichtenstein, AH, Balk, EM, Kupelnick, B, Jordan, HS, Lau, J 2006. N-3 fatty acids from fish and fish oil supplements, but not α-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. American Journal of Clinical Nutrition 84, 5–17.Google Scholar
Welch, AA, Shakya-Shrestha, S, Lentjes, AH, Wareham, NJ, Khaw, K-T 2010. Dietary intake and status of n-3 polyunsaturated fatty acids in a population of fish-eating and non-fish-eating meat-eaters, vegetarians, and vegans and the precursor-product ratio of α-linolenic acid to long-chain n-3 polyunsaturated fatty acids: results from the EPIC-Norfolk cohort. American Journal of Clinical Nutrition 92, 1040–1051.Google Scholar
Wyness, L, Weichselbaum, E, O'Connor, A, Williams, EB, Benelam, B, Riley, H, Stanner, S 2011. Red meat in the diet: an update. Nutrition Bulletin 36, 34–77.CrossRefGoogle Scholar
Yu, SM, Derr, J, Etherton, TD, Kris-Etherton, PM 1995. Plasma cholesterol-predictive equations demonstrate that stearic acid is neutral and monounsaturated fatty acids are hypocholesterolemic. American Journal of Clinical Nutrition 61, 1129–1139.Google Scholar